Showing results (601-610 of 1,661) with videos related to
Sort By:
Pageof 167
Vascular Health and Risk Management|April 27, 2012
Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA studyRoland E Schmieder, Matthias Goebel, Peter BramlageVascular Health and Risk Management|June 5, 2012
Smoking status and sex as indicators of differences in 2582 obese patients presenting for weight managementMichael J Abunassar, George A Wells, Robert R DentVascular Health and Risk Management|November 23, 2012
Treatment of prehypertension: lifestyle and/or medicationScott R Collier, Michael J LandramVascular Health and Risk Management|November 9, 2013
Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidenceMelissa E Stauffer, Lauren Weisenfluh, Alan MorrisonVascular Health and Risk Management|October 11, 2013
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trialG D Radchenko, Y M Sirenko, S M Kushnir, et al.Vascular Health and Risk Management|October 22, 2013
Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatmentAndreas Clemens, Mandy Fraessdorf, Jeffrey FriedmanVascular Health and Risk Management|October 15, 2013
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartanFotini Gialama, Nikos ManiadakisVascular Health and Risk Management|May 9, 2012
Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial diseaseRobert G Crowther, Anthony S Leicht, Warwick L Spinks, et al.Vascular Health and Risk Management|May 9, 2012
Mixed dyslipidemias in primary care patients in FranceLaurent Laforest, Baishali M Ambegaonkar, Thierry Souchet, et al.Vascular Health and Risk Management|August 27, 2016
Risk impact of edoxaban in the management of stroke and venous thromboembolismKatherine V Hurst, John Matthew O'Callaghan, Ashok HandaPageof 167